Endothelial proliferation in tumours and normal tissues: Continuous labelling studies (original) (raw)
Abstract
The proliferation rate of vascular endothelium has been studied using repeated administrations of tritiated thymidine, given every 8 h for 1 week. Five experimental mouse tumours have been investigated and compared with placenta and with normal tissues. The large difference in labelling indices between tumour and normal endothelium that has previously been detected with single injections of ([3H]dT) is confirmed by these continuous labelling studies. The potential doubling time of the tumour endothelium is estimated to be between 2.4 and 13 days for the five tumours. Tpot for the placenta is at least as short. The turnover time of the normal tissue endothelium is estimated to be 20-2000 times longer (47-23,000 days) and does not seem to differ in slow turnover tissues e.g. lung and liver from that in tissues where the parenchymal cells are rapidly turning over e.g. jejunum or skin.
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Authors
- B Hobson
- J Denekamp
Rights and permissions
About this article
Cite this article
Hobson, B., Denekamp, J. Endothelial proliferation in tumours and normal tissues: Continuous labelling studies.Br J Cancer 49, 405–413 (1984). https://doi.org/10.1038/bjc.1984.66
- Issue Date: 01 April 1984
- DOI: https://doi.org/10.1038/bjc.1984.66
This article is cited by
Mechanisms and consequences of endothelial cell senescence
- Samuel I. Bloom
- Md Torikul Islam
- Anthony J. Donato
Nature Reviews Cardiology (2023)
A high-efficiency AAV for endothelial cell transduction throughout the central nervous system
- Trevor Krolak
- Ken Y. Chan
- Benjamin E. Deverman
Nature Cardiovascular Research (2022)
Mitochondrial respiration controls neoangiogenesis during wound healing and tumour growth
- L. M. Schiffmann
- J. P. Werthenbach
- H. Kashkar
Nature Communications (2020)
Benchmarking in vitro tissue-engineered blood–brain barrier models
- Jackson G. DeStefano
- John J. Jamieson
- Peter C. Searson
Fluids and Barriers of the CNS (2018)
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
- Kabir A. Khan
- Robert S. Kerbel
Nature Reviews Clinical Oncology (2018)